NR2F6 and neoplasm: However, the data from animal experiments published by Klepsch et al. showed generally a better survival in NR2F6-deficient mice compared to NR2F6-proficient mice, suggesting that these mice benefit from the NR2F6 deficiency in terms of tumor growth and immune response concerning cancer cells (Klepsch et al. 2021).